rfhg_28917.1

Basic information about the TSS

---

TSS ID: rfhg_28917.1 TSS ID(Version3): hg_21227.1 hg_21226.1 Species: human Chr: chr2		Start: 85595717 End: 85595777 Strand: +
Source datasets	FANTOM5|EPD|DBTSS|DRA000914|ENCODE|RAMPAGE|PRJNA597322 |PRJNA4843412|DRA013844|PRJDB5282|PRJNA615891|PRJNA401781 |PRJNA548673
Protocol	CAGE|TSS_database|TSS-seq|RAMPAGE|STRIPE-seq|NETCAGE|C1CAGE |SLIC_CAGE|oligo_capping|ReCappable-seq|TIF-seq2
TSS cluster detected*	17

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3148870,EH38E2013917)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000461845.1:0 ENST00000441634.5:0 ENST00000306368.9:0 ENST00000414390.5:0 ENST00000443647.5:0 NM_016494.4:0 AF151072:0 BC002803:0 AK222700:0 CU678208:0 HQ447307:0 KJ893862:0 CR457165:0 GeneID: 51255 HGNC/MGI_ID: HGNC:28037 UniProt_ID: C9J1C6 C9J391 F8WBU5 Q9P0P0 Nearer transcript ids and distances: ENST00000456023.1:40

Gene_name: RNF181 Gene_symbol: RNF181 Gene_synonyms: HSPC238 Gene_source: HGNC:28037

TATA-Box annotation

---

Distance to TSS:	2
Nearest PromoterID:	NM_016494
Entrez ID:	51255
Nearest Unigene:	Hs.356187
Nearest Refseq:	NM_016494
Nearest Ensembl:	ENSG00000168894
Gene Name:	RNF181
Gene Alias:	HSPC238
Gene Type:	protein-coding
CpG%:	0.066667
GC%:	0.622951
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNF181 p2@RNF181
Sample		p1@RNF181	p2@RNF181
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	58.64	8.77
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	55.03	11.94
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	61.54	9.26
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	53.22	9.15
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	60.52	11.47
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	61.44	10.47
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	79.96	19.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	71.45	17.92
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.24	18.38
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	62.60	16.81
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	54.57	16.98
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	51.63	12.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	59.00	8.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	66.30	7.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	69.60	5.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	53.82	6.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	61.37	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	65.80	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	60.25	5.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	91.92	10.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	61.08	10.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	84.24	9.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	58.17	7.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	62.85	8.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	69.92	7.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	86.09	6.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	62.64	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	81.10	11.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	80.92	10.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	74.38	10.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	70.13	8.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	81.86	8.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	75.13	6.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	103.75	15.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	84.52	10.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	67.83	8.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	70.51	12.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	72.13	8.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	94.54	12.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	77.06	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	67.28	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	78.47	10.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	98.28	7.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	73.60	7.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	94.16	11.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	85.38	11.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	69.09	8.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	99.55	11.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	84.74	10.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	104.33	14.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	73.58	13.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	75.83	12.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	83.95	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	76.65	13.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	72.24	7.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	126.68	39.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	135.94	16.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	69.36	13.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	68.73	13.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	107.50	22.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	82.49	10.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	84.68	13.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	89.17	30.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	110.08	16.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	65.31	11.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	69.22	8.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	97.99	6.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	88.76	15.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	104.61	11.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	106.97	10.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	94.04	13.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	99.37	11.01
Adipocyte - breast, donor1	11376-118A8	58.92	8.08
Adipocyte - breast, donor2	11327-117E4	36.10	6.90
Adipocyte - omental, donor1	11473-119C6	53.44	6.87
Adipocyte - omental, donor2	11474-119C7	56.06	9.72
Adipocyte - omental, donor3	11475-119C8	42.87	5.36
Adipocyte - perirenal, donor1	11476-119C9	55.51	7.02
Adipocyte - subcutaneous, donor1	11259-116F8	50.58	7.70
Adipocyte - subcutaneous, donor2	11336-117F4	44.71	9.03
Adipocyte - subcutaneous, donor3	11408-118E4	40.32	5.39
Adipocyte differentiation, day04, donor1	13019-139D4	58.67	7.82
Adipocyte differentiation, day04, donor2	13022-139D7	45.04	5.92
Adipocyte differentiation, day04, donor3	13025-139E1	55.20	7.81
Adipocyte differentiation, day04, donor4	13028-139E4	59.37	7.05
Adipocyte differentiation, day08, donor1	13020-139D5	52.92	7.00
Adipocyte differentiation, day08, donor2	13023-139D8	60.36	7.75
Adipocyte differentiation, day08, donor3	13026-139E2	45.85	6.40
Adipocyte differentiation, day08, donor4	13029-139E5	47.30	10.57
Adipocyte differentiation, day12, donor1	13021-139D6	42.42	8.73
Adipocyte differentiation, day12, donor2	13024-139D9	44.21	4.27
Adipocyte differentiation, day12, donor3	13027-139E3	33.05	6.54
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	5.48
Alveolar Epithelial Cells, donor1	11510-119G7	64.53	15.91
Alveolar Epithelial Cells, donor2	11590-120G6	62.75	13.98
Alveolar Epithelial Cells, donor3	11671-122G6	63.49	21.56
Amniotic Epithelial Cells, donor1	11533-120A3	33.46	5.04
Amniotic Epithelial Cells, donor2	11613-122A2	56.90	10.04
Amniotic Epithelial Cells, donor3	11694-123A2	51.57	8.22
Anulus Pulposus Cell, donor1	11248-116E6	69.57	9.04
Anulus Pulposus Cell, donor2	11463-119B5	51.68	7.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	64.70	13.03
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	63.82	16.06
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	79.19	21.40
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	58.89	14.95
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	86.00	15.18
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	73.27	21.12
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	62.70	13.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	75.24	13.11
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	89.68	20.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	73.44	16.57
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	63.86	12.34
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	77.73	21.31
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	76.77	17.13
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	53.23	10.92
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	102.99	14.78
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	68.04	13.39
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	63.10	15.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	82.32	14.97
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	47.80	11.71
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	73.31	16.75
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	96.06	22.81
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	14.16
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	69.64	14.92
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	83.90	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	62.62	16.99
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	68.30	18.59
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	81.16	13.33
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	74.10	18.24
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	65.42	13.25
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	77.17	17.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	64.28	13.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	72.67	8.36
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	101.31	14.98
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	60.83	12.87
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	68.64	13.25
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	106.92	11.88
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	66.62	18.31
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	68.77	13.50
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	110.55	19.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	66.02	13.81
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	72.40	12.07
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	82.93	17.40
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	56.68	20.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	71.03	13.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	97.29	6.95
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	58.32	14.15
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	93.86	12.63
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	67.07	16.77
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	76.32	15.17
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	81.61	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	122.79	17.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	74.11	14.86
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	81.40	16.83
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	67.40	8.60
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	75.84	13.75
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	94.60	25.94
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	77.54	21.60
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	66.46	15.09
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	80.32	10.18
Astrocyte - cerebellum, donor1	11500-119F6	72.46	13.02
Astrocyte - cerebellum, donor2	11580-120F5	65.21	11.98
Astrocyte - cerebellum, donor3	11661-122F5	67.75	14.89
Astrocyte - cerebral cortex, donor1	11235-116D2	94.12	13.59
Astrocyte - cerebral cortex, donor2	11316-117D2	78.78	15.21
Astrocyte - cerebral cortex, donor3	11392-118C6	65.18	10.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	65.94	18.35
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	58.01	13.03
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	60.43	14.34
Basophils, donor1	12241-129G9	37.40	8.37
Basophils, donor2	12242-129H1	36.80	6.13
Basophils, donor3	12243-129H2	23.08	4.85
Bronchial Epithelial Cell, donor1	11511-119G8	45.28	6.47
Bronchial Epithelial Cell, donor2	11591-120G7	46.63	7.31
Bronchial Epithelial Cell, donor3	11672-122G7	71.74	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	84.11	10.04
Bronchial Epithelial Cell, donor5	11457-119A8	61.55	10.40
Bronchial Epithelial Cell, donor6	11461-119B3	58.26	13.13
Bronchial Epithelial Cell, donor7	11769-123I5	37.79	10.98
Burkitt's lymphoma cell line:DAUDI	10422-106C8	48.02	6.08
Burkitt's lymphoma cell line:RAJI	10476-106I8	60.32	11.88
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	82.18	15.99
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	31.03
CD14+ Monocytes, donor1	11224-116B9	16.91	2.82
CD14+ Monocytes, donor2	11305-117B9	13.36	2.60
CD14+ Monocytes, donor3	11381-118B4	21.51	1.76
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	109.25	12.45
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	69.75	5.69
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	77.58	8.88
CD14+ monocytes - mock treated, donor1	11863-125A9	61.00	12.43
CD14+ monocytes - mock treated, donor2	11873-125C1	28.36	8.45
CD14+ monocytes - mock treated, donor3	11883-125D2	42.17	7.34
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	44.53	5.86
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	27.05	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	29.26	6.69
CD14+ monocytes - treated with BCG, donor1	11860-125A6	68.14	12.53
CD14+ monocytes - treated with BCG, donor2	11870-125B7	49.50	13.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	74.86	15.02
CD14+ monocytes - treated with Candida, donor1	11868-125B5	26.69	3.28
CD14+ monocytes - treated with Candida, donor2	11878-125C6	25.35	5.28
CD14+ monocytes - treated with Candida, donor3	11888-125D7	24.41	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	44.77	6.84
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.12	5.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	60.79	13.95
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	45.99	5.49
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	16.74	5.66
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	27.50	5.67
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	89.04	20.71
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	69.78	17.62
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	72.80	13.05
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	29.94	5.14
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	20.08	5.64
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.50	6.14
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	47.60	14.47
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	43.11	7.81
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	70.27	13.36
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	28.66	4.09
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	22.72	3.94
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	33.64	5.34
CD14+CD16+ Monocytes, donor1	11789-124B7	54.71	9.81
CD14+CD16+ Monocytes, donor2	11801-124D1	78.08	9.70
CD14+CD16+ Monocytes, donor3	11912-125G4	81.01	6.93
CD14+CD16- Monocytes, donor1	11788-124B6	85.65	9.50
CD14+CD16- Monocytes, donor2	11799-124C8	72.48	7.68
CD14+CD16- Monocytes, donor3	11910-125G2	38.80	6.02
CD14-CD16+ Monocytes, donor1	11790-124B8	134.48	14.29
CD14-CD16+ Monocytes, donor2	11800-124C9	75.53	10.54
CD14-CD16+ Monocytes, donor3	11911-125G3	82.96	6.95
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	16.26
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	88.14	13.56
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	67.31	18.64
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	85.29	15.99
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	82.55	11.79
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	51.24	18.25
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	74.51	17.26
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	84.37	22.41
CD19+ B Cells, donor1	11544-120B5	15.62	5.75
CD19+ B Cells, donor2	11624-122B4	25.39	5.80
CD19+ B Cells, donor3	11705-123B4	15.14	5.55
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	52.53	8.08
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	59.12	7.59
CD34+ Progenitors, donor1	11545-120B6	52.21	15.06
CD34+ Progenitors, donor2	11625-122B5	33.15	6.74
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	81.16	16.53
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	96.73	19.17
CD4+ T Cells, donor1	11225-116C1	27.85	6.07
CD4+ T Cells, donor2	11306-117C1	27.56	6.74
CD4+ T Cells, donor3	11382-118B5	23.18	4.57
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	54.88	11.49
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	63.79	11.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	60.94	11.50
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	72.54	15.17
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	83.58	16.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	66.19	11.42
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	72.19	12.54
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	75.61	18.22
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	67.69	18.38
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	68.48	17.12
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	55.88	9.24
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	53.55	7.17
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	80.82	12.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	88.88	13.70
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	43.24	8.43
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.88	14.47
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	41.24	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	69.35	12.61
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	54.80	8.45
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	53.38	8.20
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	70.78	15.17
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.99	17.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	33.56	10.02
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	87.59	15.84
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	68.32	18.46
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	99.10	36.29
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	56.22	16.89
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	64.54	14.97
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	58.52	21.56
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	68.04	20.77
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	106.64	24.93
CD8+ T Cells, donor1	11226-116C2	27.50	5.57
CD8+ T Cells, donor2	11307-117C2	21.78	7.88
CD8+ T Cells, donor3	11383-118B6	23.23	6.06
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	47.25	11.93
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	34.51	8.39
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	47.06	11.76
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	51.94	20.11
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	36.24	8.40
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.02	8.87
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	44.76	12.60
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.32	12.63
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	36.82	11.96
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	48.30	14.49
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	50.84	16.27
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	47.69	15.19
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	30.64	9.63
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.35	6.83
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	11.19
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	39.98	10.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	37.69	10.07
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	30.88	11.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	45.63	15.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	49.21	15.07
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	42.32	17.31
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	53.93	16.45
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	57.15	13.01
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	38.58	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	42.56	13.65
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.06	10.49
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	65.11	12.02
Cardiac Myocyte, donor1	11525-119I4	45.69	5.48
Cardiac Myocyte, donor2	11605-120I3	46.94	8.40
Cardiac Myocyte, donor3	11686-122I3	76.82	10.10
Chondrocyte - de diff, donor1	11261-116G1	41.25	8.32
Chondrocyte - de diff, donor2	11338-117F6	47.62	7.11
Chondrocyte - de diff, donor3	11410-118E6	45.97	7.62
Chondrocyte - re diff, donor2	11339-117F7	54.61	9.85
Chondrocyte - re diff, donor3	11411-118E7	61.47	9.30
Ciliary Epithelial Cells, donor1	11242-116D9	80.68	14.57
Ciliary Epithelial Cells, donor2	11323-117D9	62.85	11.76
Ciliary Epithelial Cells, donor3	11399-118D4	51.06	9.12
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	64.28	17.33
Corneal Epithelial Cells, donor1	11526-119I5	32.94	8.34
Corneal Epithelial Cells, donor2	11606-120I4	45.50	9.10
Corneal Epithelial Cells, donor3	11687-122I4	49.85	9.46
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	87.50	8.58
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	106.92	13.88
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	100.07	10.35
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	63.82	8.53
Dendritic Cells - plasmacytoid, donor1	11228-116C4	50.22	8.88
Dendritic Cells - plasmacytoid, donor2	11309-117C4	51.58	14.36
Dendritic Cells - plasmacytoid, donor3	11385-118B8	46.46	19.36
Endothelial Cells - Aortic, donor0	11207-116A1	78.05	18.51
Endothelial Cells - Aortic, donor1	11263-116G3	65.72	18.78
Endothelial Cells - Aortic, donor2	11340-117F8	73.53	13.29
Endothelial Cells - Aortic, donor3	11412-118E8	70.38	11.80
Endothelial Cells - Artery, donor1	11264-116G4	58.76	12.22
Endothelial Cells - Artery, donor2	11341-117F9	59.29	10.82
Endothelial Cells - Artery, donor3	11413-118E9	67.32	15.25
Endothelial Cells - Lymphatic, donor1	11236-116D3	67.60	10.20
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.60	6.69
Endothelial Cells - Lymphatic, donor3	11393-118C7	42.00	7.61
Endothelial Cells - Microvascular, donor1	11265-116G5	63.29	12.48
Endothelial Cells - Microvascular, donor2	11342-117G1	72.89	18.74
Endothelial Cells - Microvascular, donor3	11414-118F1	42.25	9.07
Endothelial Cells - Thoracic, donor1	11266-116G6	69.22	12.80
Endothelial Cells - Thoracic, donor2	11343-117G2	70.76	13.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	79.27	12.80
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.48	11.51
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.63	13.19
Endothelial Cells - Vein, donor1	11267-116G7	83.04	18.20
Endothelial Cells - Vein, donor2	11344-117G3	81.03	11.87
Endothelial Cells - Vein, donor3	11416-118F3	72.69	14.76
Eosinophils, donor1	12244-129H3	30.49	0.00
Eosinophils, donor2	12245-129H4	49.51	11.55
Eosinophils, donor3	12246-129H5	46.37	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	41.29	4.89
Esophageal Epithelial Cells, donor2	11587-120G3	35.36	4.16
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	83.74	11.90
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	75.98	12.92
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	91.87	13.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	67.92	11.40
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	56.09	9.83
Fibroblast - Aortic Adventitial, donor2	11326-117E3	59.27	10.13
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.77	4.74
Fibroblast - Aortic Adventitial, donor3	11401-118D6	53.48	10.96
Fibroblast - Cardiac, donor1	11268-116G8	52.17	8.62
Fibroblast - Cardiac, donor2	11345-117G4	65.94	9.10
Fibroblast - Cardiac, donor3	11417-118F4	70.97	14.83
Fibroblast - Cardiac, donor4	11452-119A3	29.40	4.85
Fibroblast - Cardiac, donor5	11456-119A7	58.38	10.03
Fibroblast - Cardiac, donor6	11460-119B2	55.33	8.64
Fibroblast - Choroid Plexus, donor1	11492-119E7	41.94	7.10
Fibroblast - Choroid Plexus, donor2	11572-120E6	38.40	5.61
Fibroblast - Choroid Plexus, donor3	11653-122E6	43.94	5.86
Fibroblast - Conjunctival, donor1	11531-120A1	50.74	10.15
Fibroblast - Conjunctival, donor3	11692-122I9	39.69	4.58
Fibroblast - Dermal, donor1	11269-116G9	37.80	11.03
Fibroblast - Dermal, donor2	11346-117G5	67.45	19.34
Fibroblast - Dermal, donor3	11418-118F5	48.60	11.97
Fibroblast - Dermal, donor4	11450-119A1	36.17	8.14
Fibroblast - Dermal, donor5	11454-119A5	49.37	8.02
Fibroblast - Dermal, donor6	11458-119A9	47.27	11.53
Fibroblast - Gingival, donor1	11237-116D4	65.18	7.91
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	65.24	10.48
Fibroblast - Gingival, donor2	11318-117D4	68.00	11.20
Fibroblast - Gingival, donor3	11394-118C8	32.68	5.80
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	58.18	9.35
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	44.23	5.64
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	52.85	13.41
Fibroblast - Gingival, donor6 (control)	11922-125H5	59.91	11.63
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	25.41	10.94
Fibroblast - Gingival, donor7 (control)	11924-125H7	55.87	10.38
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	62.72	13.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	71.52	16.56
Fibroblast - Gingival, donor9 (control)	11927-125I1	53.85	9.24
Fibroblast - Lung, donor1	11270-116H1	57.09	2.72
Fibroblast - Lung, donor2	11347-117G6	35.81	8.95
Fibroblast - Lung, donor3	11419-118F6	57.19	14.35
Fibroblast - Lymphatic, donor1	11506-119G3	37.49	7.50
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	8.39
Fibroblast - Lymphatic, donor3	11667-122G2	25.47	4.48
Fibroblast - Mammary, donor1	11540-120B1	25.98	5.68
Fibroblast - Mammary, donor2	11620-122A9	35.95	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	75.46	12.61
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.59	8.34
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.05	7.65
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	43.89	6.87
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	79.92	14.58
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	47.90	6.96
Fibroblast - Pulmonary Artery, donor1	11250-116E8	88.21	14.04
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	39.62	9.14
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	61.47	10.69
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	55.75	13.05
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.00	4.76
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	48.31	7.46
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	51.64	7.88
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.68	6.02
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	52.90	10.36
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.95	4.56
Fibroblast - skin normal, donor1	11553-120C5	50.70	8.20
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	44.91	7.42
Fibroblast - skin normal, donor2	11561-120D4	55.46	8.74
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.62	8.16
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	67.02	7.29
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	45.99	7.35
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	22.66	7.55
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	56.46	13.95
Fibroblast - skin walker warburg, donor1	11554-120C6	69.83	14.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	110.09	22.27
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	66.48
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	19.17	6.10
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	74.72	14.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	49.45	11.71
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	39.35	11.75
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	101.05	15.31
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	126.34	13.40
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	138.92	17.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	76.38	15.44
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	69.18	14.61
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	79.45	8.92
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.56	16.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.86	13.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	103.04	14.59
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	67.41	12.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	52.83	9.24
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.25	9.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	52.90	13.01
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.20	10.80
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	65.46	11.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	61.38	10.04
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	51.57	9.72
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	60.98	11.37
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	73.28	7.39
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	37.67	9.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	56.75	9.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	56.46	7.66
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.14	8.48
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	46.64	10.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.87	7.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.43	8.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	44.15	7.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.49	8.65
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.33	9.60
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.51	9.28
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	45.77	7.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	51.86	8.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	47.61	7.27
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	45.38	7.26
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	49.60	7.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	55.48	8.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	45.29	9.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	50.30	9.33
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	62.34	9.12
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	46.52	10.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	57.74	7.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	56.95	9.26
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	30.37	7.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	54.55	6.69
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	42.84	6.89
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.49	7.12
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	49.06	7.59
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	44.24	7.19
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	48.25	5.70
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	2.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.27	7.65
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.38	6.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	36.85	3.56
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	69.47	7.96
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	52.85	12.79
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	49.30	13.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	149.58	13.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	141.28	11.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	80.25	10.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	128.69	44.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	103.66	17.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	165.26	20.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	66.08	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	105.78	13.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	74.95	9.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	94.24	11.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	63.41	12.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	63.75	12.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	83.02	10.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	88.31	8.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	162.88	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.63	14.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	78.73	10.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	130.45	16.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	106.04	17.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	94.12	14.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	142.25	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	87.26	15.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	112.13	13.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	127.75	20.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	84.76	16.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	83.53	14.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	72.06	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	93.90	9.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.73	9.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	73.25	16.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	89.74	10.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	88.80	11.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	108.60	16.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	113.77	14.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	62.76	11.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	74.60	12.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	78.79	13.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	100.45	10.68
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	67.34	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	51.56	8.73
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	109.07	17.99
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	36.16	4.76
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	50.55	7.10
Hep-2 cells mock treated, biol_rep1	11898-125E8	49.32	8.01
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.98	6.25
Hep-2 cells mock treated, biol_rep3	11900-125F1	33.44	5.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.17	9.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	41.26	6.02
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.09	5.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	58.78	8.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	40.31	4.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	34.92	7.05
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	55.40	7.83
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	48.04	7.79
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	87.25	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	52.91	5.64
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	47.95	7.27
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	70.63	14.69
Hepatocyte, donor1	11523-119I2	66.58	7.26
Hepatocyte, donor2	11603-120I1	67.87	6.46
Hepatocyte, donor3	11684-122I1	33.74	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.77	18.93
Intestinal epithelial cells (polarized), donor1	11246-116E4	80.22	7.34
Iris Pigment Epithelial Cells, donor1	11530-119I9	58.04	9.33
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	111.44	41.39
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	100.13	40.05
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	96.91	24.92
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	117.63	22.52
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	249.23	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	64.07	20.50
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	127.98	18.28
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	105.58	25.99
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	105.04	13.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	68.98	21.78
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	72.79	31.76
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	108.65	28.82
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	120.48	52.38
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	110.86	31.49
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	102.08	29.39
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	117.08	29.27
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	95.61	23.26
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	112.69	20.93
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	35.84
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	103.49	22.82
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	92.36	20.57
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	98.05	35.36
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	82.17	31.39
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	93.94	27.38
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	78.00	28.12
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	44.23
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	97.93	24.75
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	92.74	26.68
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	49.29
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	73.97	18.49
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	85.67	38.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	94.83	31.61
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	85.69	16.42
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	106.19	36.50
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	90.13	29.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	24.58
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	81.72	31.43
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	103.61	21.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	110.65	37.62
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	64.84	16.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	75.86	20.05
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	103.49	29.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	66.21	13.94
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	97.08	27.74
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	63.73	9.70
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	48.44	11.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	62.59	24.85
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	130.09	27.23
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	108.91	38.07
Keratinocyte - epidermal, donor1	11272-116H3	33.37	6.53
Keratinocyte - epidermal, donor2	11349-117G8	36.31	10.54
Keratinocyte - epidermal, donor3	11421-118F8	40.23	10.13
Keratinocyte - oral, donor1	11251-116E9	68.00	12.37
Keratocytes, donor1	11527-119I6	99.37	20.63
Keratocytes, donor2	11607-120I5	38.67	14.06
Keratocytes, donor3	11688-122I5	52.36	9.68
Krukenberg tumor cell line:HSKTC	10687-109F3	39.56	8.79
Lens Epithelial Cells, donor1	11529-119I8	60.41	11.87
Lens Epithelial Cells, donor2	11609-120I7	53.74	10.15
Lens Epithelial Cells, donor3	11690-122I7	59.33	8.27
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	62.96	10.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	53.30	14.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	71.94	9.60
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	75.28	16.13
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	70.60	10.72
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	75.15	11.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	60.74	16.42
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	65.73	16.69
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	77.69	9.57
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	54.19	13.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	67.28	7.95
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	99.24	12.03
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	57.84	13.94
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	57.25	10.97
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	73.21	11.40
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	64.98	10.78
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	71.70	10.91
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	76.86	11.89
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	66.81	9.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	70.58	17.87
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	89.12	15.68
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	62.08	11.64
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	65.98	12.39
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	71.00	13.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	72.06	17.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	55.28	11.94
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	72.18	10.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	71.54	13.76
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	62.84	10.91
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	71.99	12.19
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	60.57	13.08
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	64.17	12.24
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	73.59	10.78
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.83	10.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	62.26	10.38
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	76.86	11.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	61.11	12.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	62.69	11.87
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	69.56	9.66
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	75.02	9.60
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	70.78	16.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	92.12	15.25
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	75.92	20.05
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	54.88	13.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	91.82	12.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	61.13	12.13
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	61.98	12.81
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	60.57	10.44
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	106.50	20.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	107.40	27.62
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	86.10	22.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	118.48	24.54
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	77.37	14.07
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	87.79	23.35
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	100.99	17.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	82.07	17.84
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	102.69	22.17
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	102.37	22.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	76.08	22.96
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	96.47	19.37
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	110.92	19.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	62.10	13.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	51.97	15.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	94.75	21.90
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	79.51	14.41
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	89.75	21.92
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	103.69	20.25
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	85.62	15.49
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	98.50	21.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	83.24	16.26
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	63.88	26.79
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	96.67	24.39
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	85.79	21.22
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	64.73	14.38
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	96.50	22.27
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	107.31	30.98
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	87.50	28.78
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	105.15	26.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	94.54	30.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	84.51	18.87
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	95.35	22.14
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	109.88	21.54
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	76.93	10.46
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	83.61	21.18
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	96.49	18.09
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	66.79	16.27
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	99.29	23.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	109.20	17.50
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	81.76	12.80
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	102.08	17.87
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	97.15	27.91
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	66.66	14.14
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	92.23	25.56
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	125.60	26.75
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	82.50	15.87
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	103.24	17.61
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	104.67	26.89
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	113.44	29.89
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	109.51	22.20
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	85.62	22.58
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	102.07	23.63
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	94.63	26.14
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	101.55	25.82
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	116.68	21.38
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	94.63	26.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	95.66	29.03
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	116.24	28.02
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	83.14	17.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	91.69	24.60
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	103.79	22.52
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	103.37	27.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	95.19	21.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	84.59	24.99
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	78.32	21.87
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	86.89	18.23
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	82.31	15.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	106.78	19.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	93.99	21.17
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	71.35	13.30
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	101.09	25.67
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	96.49	25.06
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	82.75	16.09
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	108.50	21.60
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	89.13	24.05
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	76.61	21.56
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	86.12	22.47
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	94.75	24.27
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	85.60	20.46
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	92.46	23.70
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	98.35	26.09
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	95.70	21.92
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	90.92	27.88
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	95.45	23.86
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	62.24	22.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	119.67	24.50
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	102.00	27.61
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	83.17	16.96
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	82.41	20.05
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	130.76	21.84
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	90.85	17.24
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	143.42	29.10
Macrophage - monocyte derived, donor1	11232-116C8	90.48	10.48
Macrophage - monocyte derived, donor2	11313-117C8	53.22	8.62
Macrophage - monocyte derived, donor3	11389-118C3	61.21	8.91
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	87.62	28.14
Mallassez-derived cells, donor2	11929-125I3	52.76	13.47
Mallassez-derived cells, donor3	11930-125I4	51.56	12.37
Mammary Epithelial Cell, donor1	11273-116H4	65.67	11.46
Mammary Epithelial Cell, donor2	11350-117G9	39.38	7.53
Mammary Epithelial Cell, donor3	11422-118F9	46.39	8.23
Mast cell - stimulated, donor1	11487-119E2	39.32	6.78
Mast cell, donor1	11563-120D6	50.72	6.70
Mast cell, donor2	11565-120D8	37.74	7.43
Mast cell, donor3	11566-120D9	42.55	8.33
Mast cell, donor4	11567-120E1	32.27	7.09
Mast cell, expanded and stimulated, donor5	11940-126A5	55.34	8.98
Mast cell, expanded and stimulated, donor8	11942-126A7	61.29	19.26
Mast cell, expanded, donor5	11939-126A4	66.65	10.44
Mast cell, expanded, donor8	11941-126A6	42.34	6.36
Melanocyte - dark, donor1	11502-119F8	56.61	7.96
Melanocyte - dark, donor2	11582-120F7	53.99	10.04
Melanocyte - dark, donor3	11663-122F7	41.15	6.23
Melanocyte - light, donor1	11274-116H5	32.20	3.29
Melanocyte - light, donor2	11351-117H1	47.09	6.82
Melanocyte - light, donor3	11423-118G1	35.56	7.81
Melanocyte, donor1 (MC+1)	12641-134G4	31.55	7.81
Melanocyte, donor2 (MC+2)	12739-135I3	51.10	5.65
Melanocyte, donor3 (MC+3)	12837-137B2	37.23	2.68
Meningeal Cells, donor1	11493-119E8	39.58	8.19
Meningeal Cells, donor2	11573-120E7	39.61	8.36
Meningeal Cells, donor3	11654-122E7	46.05	9.78
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	73.00	12.83
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	53.54	8.86
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	22.34	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	34.01	5.23
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	51.67	10.76
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	40.24	7.41
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	38.20	6.53
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	57.80	15.38
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	39.45	13.15
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	56.67	18.01
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	58.31	8.73
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	36.43	5.95
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	66.31	7.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	42.14	3.86
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	11.68
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	57.00	6.40
Mesenchymal stem cells - adipose, donor0	11217-116B2	68.05	16.30
Mesenchymal stem cells - hepatic, donor0	11218-116B3	68.17	6.57
Mesenchymal stem cells - umbilical, donor0	11214-116A8	56.60	13.06
Mesothelial Cells, donor1	11247-116E5	71.07	12.99
Mesothelial Cells, donor2	12156-128G5	58.05	20.02
Mesothelial Cells, donor3	11402-118D7	43.94	10.77
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	64.82	10.80
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	71.91	9.60
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	50.06	11.19
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	13.83	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	55.79	8.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	48.33	8.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	71.07	11.26
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.55	10.24
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	60.56	6.50
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	41.97	5.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	50.44	7.96
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	66.11	12.54
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	44.99	6.58
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	29.47	7.37
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	35.77	4.17
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	8.38
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	50.68	10.29
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.99	6.18
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	24.33	4.42
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	39.37	6.91
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	38.91	5.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.08	5.91
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.77	9.01
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	40.46	4.45
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	33.29	5.48
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.84	6.08
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	34.25	5.98
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	32.06	6.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	15.26	3.27
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	47.57	6.25
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	36.42	6.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	15.08	6.86
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	42.55	8.01
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	6.12
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	42.48	10.51
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	6.40
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	46.36	8.43
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	22.27	4.18
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	8.84
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	62.56	11.62
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.75	3.50
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	29.47	7.46
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	65.09	11.22
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.85	5.40
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	30.89	7.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.33	6.64
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.90	9.60
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	43.31	14.44
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	49.87	9.24
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	28.46	5.12
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	49.05	9.53
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	56.75	11.14
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	37.32	8.15
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	3.81
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	47.24	8.54
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	57.17	16.46
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	54.24	7.63
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	69.75	13.38
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	49.31	10.17
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	48.92	10.24
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	66.48	12.50
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	63.42	9.59
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	51.48	9.12
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	66.45	15.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	68.62	16.43
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	103.04	13.60
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	62.24	9.23
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	113.01	11.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	80.20	5.35
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	72.61	8.54
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	78.90	16.83
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	93.70	8.70
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	66.12	9.31
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	66.09	5.26
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	54.87	4.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	67.97	7.24
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	39.78	5.16
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	46.54	3.66
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	6.22
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	52.91	11.76
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	15.46
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	74.74	9.09
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	55.23	9.70
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	42.22	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	65.49	11.44
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	88.27	9.72
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	46.82	4.53
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	65.25	16.31
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.47	6.89
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	48.60	7.84
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	38.05	5.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	44.66	8.35
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	84.04	21.30
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	67.03	19.15
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	25.84	4.76
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	20.21	14.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	30.55	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	63.92	14.88
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	40.26	4.86
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	47.09	10.51
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	54.60	9.93
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	43.58	8.66
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	49.64	8.61
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	31.84	3.76
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	47.20	5.65
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	40.31	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	33.62	5.40
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	66.29	10.50
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.04	4.88
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	47.98	6.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	30.94	5.63
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.91	3.68
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	47.88	7.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	65.18	21.73
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	12.64
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	43.22	4.23
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	41.07	3.39
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.50	6.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	60.52	7.73
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	36.99	8.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	58.16	8.12
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	42.06	8.33
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	29.72	2.79
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	77.57	13.62
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	31.94	9.78
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	25.28	3.49
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	70.56	14.02
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.98	8.82
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	50.53	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	54.56	7.44
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	45.56	9.57
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	68.96	9.07
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	58.13	11.94
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	42.69	8.13
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	64.02	6.10
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	58.23	8.50
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	24.21	6.66
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	64.87	10.28
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	44.21	15.87
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	15.17
Myoblast, donor1	11241-116D8	69.44	16.40
Myoblast, donor2	11322-117D8	53.70	10.93
Myoblast, donor3	11398-118D3	55.16	11.60
NK T cell leukemia cell line:KHYG-1	10777-110G3	63.04	7.30
Natural Killer Cells, donor1	11230-116C6	29.83	5.54
Natural Killer Cells, donor2	11311-117C6	28.04	5.43
Natural Killer Cells, donor3	11387-118C1	24.66	4.97
Neural stem cells, donor1	11275-116H6	35.21	9.44
Neural stem cells, donor2	11352-117H2	11.55	5.78
Neurons, donor1	11494-119E9	58.03	12.52
Neurons, donor2	11574-120E8	53.94	14.31
Neurons, donor3	11655-122E8	59.20	18.91
Neutrophils, donor1	11233-116C9	33.41	5.57
Neutrophils, donor2	11314-117C9	23.19	5.80
Neutrophils, donor3	11390-118C4	31.76	4.28
Nucleus Pulposus Cell, donor1	11252-116F1	46.07	6.41
Nucleus Pulposus Cell, donor2	11409-118E5	59.59	9.77
Nucleus Pulposus Cell, donor3	11462-119B4	53.55	8.82
Olfactory epithelial cells, donor1	11933-125I7	48.73	4.27
Olfactory epithelial cells, donor2	11934-125I8	59.92	12.01
Olfactory epithelial cells, donor3	11935-125I9	57.32	7.26
Olfactory epithelial cells, donor4	11936-126A1	68.96	7.40
Oligodendrocyte - precursors, donor1	11496-119F2	66.20	10.83
Osteoblast - differentiated, donor1	11276-116H7	60.19	10.21
Osteoblast - differentiated, donor2	11353-117H3	105.17	14.86
Osteoblast - differentiated, donor3	11425-118G3	83.80	12.41
Osteoblast, donor1	11277-116H8	165.34	24.82
Osteoblast, donor2	11354-117H4	37.22	9.13
Osteoblast, donor3	11426-118G4	76.96	12.44
Pancreatic stromal cells, donor1	11249-116E7	54.50	9.52
Pericytes, donor1	11491-119E6	60.75	8.46
Pericytes, donor2	11571-120E5	62.25	11.54
Pericytes, donor3	11652-122E5	86.06	14.44
Perineurial Cells, donor1	11499-119F5	55.27	10.85
Perineurial Cells, donor2	11579-120F4	43.89	7.08
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	40.16	5.10
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	30.61	5.14
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	22.39	5.31
Placental Epithelial Cells, donor1	11278-116H9	117.91	19.13
Placental Epithelial Cells, donor2	11355-117H5	49.90	22.18
Placental Epithelial Cells, donor3	11427-118G5	48.69	8.05
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	71.20	6.65
Preadipocyte - breast, donor1	11467-119B9	53.46	7.50
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	44.12	6.92
Preadipocyte - breast, donor2	11328-117E5	58.76	11.48
Preadipocyte - omental, donor1	11468-119C1	49.87	7.14
Preadipocyte - omental, donor2	11329-117E6	43.65	10.04
Preadipocyte - omental, donor3	11403-118D8	51.00	9.17
Preadipocyte - perirenal, donor1	11469-119C2	61.02	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	101.04	18.73
Preadipocyte - subcutaneous, donor2	11356-117H6	61.62	18.59
Preadipocyte - subcutaneous, donor3	11428-118G6	66.24	18.73
Preadipocyte - visceral, donor1	11280-116I2	54.30	12.67
Preadipocyte - visceral, donor2	11357-117H7	45.56	11.04
Preadipocyte - visceral, donor3	11429-118G7	57.47	11.18
Prostate Epithelial Cells (polarized), donor1	11253-116F2	68.03	8.60
Prostate Epithelial Cells, donor2	11331-117E8	41.98	11.10
Prostate Epithelial Cells, donor3	11404-118D9	40.23	10.84
Prostate Stromal Cells, donor1	11254-116F3	68.57	12.42
Prostate Stromal Cells, donor2	11332-117E9	70.11	13.27
Prostate Stromal Cells, donor3	11405-118E1	54.95	10.22
Renal Cortical Epithelial Cells, donor1	11516-119H4	40.51	10.22
Renal Cortical Epithelial Cells, donor2	11596-120H3	72.08	12.55
Renal Epithelial Cells, donor1	11517-119H5	31.45	7.61
Renal Epithelial Cells, donor2	11597-120H4	41.26	15.65
Renal Epithelial Cells, donor3	11678-122H4	62.57	10.90
Renal Glomerular Endothelial Cells, donor1	11514-119H2	51.06	11.57
Renal Glomerular Endothelial Cells, donor2	11594-120H1	67.79	15.23
Renal Glomerular Endothelial Cells, donor3	11675-122H1	51.51	12.43
Renal Glomerular Endothelial Cells, donor4	11783-124B1	25.95	5.99
Renal Mesangial Cells, donor1	11518-119H6	48.86	11.00
Renal Mesangial Cells, donor2	11598-120H5	43.26	6.90
Renal Mesangial Cells, donor3	11679-122H5	46.33	8.60
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	63.62	14.23
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	45.96	13.49
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	54.96	12.54
Retinal Pigment Epithelial Cells, donor0	11215-116A9	75.45	14.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.78	6.54
Retinal Pigment Epithelial Cells, donor2	11608-120I6	40.14	8.23
Retinal Pigment Epithelial Cells, donor3	11689-122I6	31.87	6.52
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	63.61	9.76
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	60.75	7.15
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	97.42	15.96
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	68.45	13.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	45.51	8.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	67.53	11.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	57.67	13.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	56.07	12.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	68.18	13.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	61.71	11.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	37.51	9.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	60.51	12.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	74.18	11.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	39.31	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	64.50	11.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.50	15.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	28.87	4.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	58.69	10.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	47.16	8.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	39.81	7.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	53.63	11.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	60.53	9.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.25	8.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	53.82	11.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	60.50	10.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	39.57	7.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	56.04	10.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	58.83	11.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.04	6.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	63.89	13.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	61.50	12.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	40.85	6.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	79.41	16.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	53.89	7.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.28	8.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	57.56	10.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	52.83	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.25	8.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	59.67	12.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	60.91	12.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.65	5.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	58.30	15.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	43.18	11.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	33.18	7.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	59.29	11.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	49.18	10.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	38.99	6.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.55	10.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	53.49	9.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.24	8.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	56.62	11.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	74.84	21.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	40.09	9.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	59.71	8.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	55.12	11.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	42.62	8.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	59.76	12.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	57.69	8.41
Schwann Cells, donor1	11498-119F4	64.88	12.60
Schwann Cells, donor2	11578-120F3	64.65	3.40
Schwann Cells, donor3	11659-122F3	58.06	12.49
Sebocyte, donor1	11220-116B5	31.22	8.22
Sebocyte, donor2	11301-117B5	46.42	9.65
Sebocyte, donor3	11378-118B1	37.72	7.83
Sertoli Cells, donor1	11255-116F4	66.26	8.28
Sertoli Cells, donor2	11333-117F1	56.49	11.30
Skeletal Muscle Cells, donor1	11281-116I3	79.09	14.87
Skeletal Muscle Cells, donor2	11358-117H8	80.24	12.29
Skeletal Muscle Cells, donor3	11430-118G8	135.44	23.41
Skeletal Muscle Cells, donor4	11451-119A2	58.44	10.05
Skeletal Muscle Cells, donor5	11455-119A6	51.13	11.45
Skeletal Muscle Cells, donor6	11459-119B1	61.41	12.93
Skeletal Muscle Satellite Cells, donor1	11240-116D7	69.05	10.33
Skeletal Muscle Satellite Cells, donor2	11321-117D7	49.66	9.70
Skeletal Muscle Satellite Cells, donor3	11397-118D2	47.42	12.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	61.84	9.94
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	104.22	26.06
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	93.98	19.68
Skin - palm, donor1	10286-104F7	21.49	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	38.06	7.93
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	22.08	10.63
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	41.16	8.83
Small Airway Epithelial Cells, donor1	11256-116F5	69.09	18.35
Small Airway Epithelial Cells, donor2	11334-117F2	53.87	16.60
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	43.35	6.34
Small Airway Epithelial Cells, donor3	11406-118E2	53.06	15.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	57.71	12.34
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	27.12	4.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	139.90	22.93
Smooth Muscle Cells - Aortic, donor1	11283-116I5	65.63	8.18
Smooth Muscle Cells - Aortic, donor2	11360-117I1	125.22	25.20
Smooth Muscle Cells - Aortic, donor3	11432-118H1	134.43	31.68
Smooth Muscle Cells - Bladder, donor1	11519-119H7	44.03	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	104.33	19.16
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	73.37	13.74
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	96.79	17.28
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	85.63	12.37
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	75.60	10.63
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	52.82	8.68
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	54.17	11.06
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	44.14	6.39
Smooth Muscle Cells - Carotid, donor1	11285-116I7	112.39	12.63
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	113.49	25.75
Smooth Muscle Cells - Colonic, donor1	11239-116D6	68.72	11.95
Smooth Muscle Cells - Colonic, donor2	11320-117D6	49.72	7.32
Smooth Muscle Cells - Colonic, donor3	11396-118D1	45.87	10.29
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	134.73	28.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	151.98	28.02
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	89.36	12.85
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	52.23	10.92
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	58.19	7.22
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	58.17	11.98
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	83.74	17.75
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	105.06	21.74
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	55.63	9.80
Smooth Muscle Cells - Prostate, donor1	11257-116F6	52.07	9.99
Smooth Muscle Cells - Prostate, donor2	11335-117F3	53.47	9.02
Smooth Muscle Cells - Prostate, donor3	11465-119B7	41.85	6.34
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	84.58	16.59
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	90.77	12.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	74.95	11.63
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	101.85	16.74
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	103.50	24.74
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	111.25	21.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	39.23	8.26
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.40	14.16
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	39.71	6.07
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	115.85	19.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	106.57	21.16
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	93.83	17.11
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.43	10.62
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	65.69	10.31
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	31.43	10.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	108.87	18.10
Smooth Muscle Cells - Uterine, donor1	11258-116F7	47.72	10.61
Smooth Muscle Cells - Uterine, donor3	11466-119B8	103.28	19.02
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	36.73	4.47
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	58.97	9.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	84.06	17.48
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	69.71	13.30
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.37	13.91
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	67.75	18.91
Smooth muscle cells - airway, control, donor1	11966-126D4	61.46	10.16
Smooth muscle cells - airway, control, donor2	11967-126D5	46.32	7.99
Smooth muscle cells - airway, control, donor3	11968-126D6	51.00	4.60
Smooth muscle cells - airway, control, donor4	11969-126D7	54.54	5.96
Synoviocyte, donor1	11291-117A4	61.10	9.76
Synoviocyte, donor2	11368-117I9	57.83	9.22
Synoviocyte, donor3	11440-118H9	42.67	5.14
Trabecular Meshwork Cells, donor1	11532-120A2	35.02	7.50
Trabecular Meshwork Cells, donor2	11612-122A1	27.75	11.89
Trabecular Meshwork Cells, donor3	11693-123A1	37.05	12.97
Tracheal Epithelial Cells, donor1	11292-117A5	76.99	13.40
Tracheal Epithelial Cells, donor2	11369-118A1	70.74	11.98
Tracheal Epithelial Cells, donor3	11441-118I1	66.43	12.60
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	58.81	7.63
Urethra, donor2	10319-105A4	37.77	8.99
Urothelial Cells, donor1	11520-119H8	46.49	7.44
Urothelial Cells, donor2	11600-120H7	52.47	9.21
Urothelial Cells, donor3	11681-122H7	33.69	5.73
Urothelial cells, donor0	11216-116B1	58.40	8.47
Whole blood (ribopure), donor090309, donation1	12179-129A1	64.95	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	62.90	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	35.60	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	52.34	9.30
Whole blood (ribopure), donor090325, donation2	12177-128I8	49.39	9.88
Whole blood (ribopure), donor090612, donation1	12182-129A4	61.43	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	42.22	5.51
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	8.22
Wilms' tumor cell line:G-401	10809-111A8	42.56	9.87
Wilms' tumor cell line:HFWT	10597-108E3	39.60	11.44
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	22.90	6.98
achilles tendon, donor2	10292-104G4	18.60	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	59.15	10.71
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.05	11.84
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	39.29	14.60
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	77.28	23.40
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	43.29	3.37
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	96.22	13.32
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.83	6.81
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	72.71	12.34
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	31.04	4.49
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	60.57	14.76
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	42.32	9.38
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	15.60
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	42.76	9.99
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	39.87	14.24
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	49.97	9.64
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	45.55	6.51
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	74.44	8.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.45	4.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	51.63	12.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	66.42	12.74
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	56.81	15.65
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	32.74	6.46
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	36.36	8.01
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	79.90	33.45
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	43.69	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	57.57	10.47
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	149.96	15.00
adenocarcinoma cell line:IM95m	10796-110I4	44.98	8.01
adipose tissue, adult, pool1	10010-101C1	37.85	4.65
adipose, donor1	10184-103D4	96.17	25.22
adipose, donor2	10185-103D5	56.77	12.57
adipose, donor3	10186-103D6	57.18	12.53
adipose, donor4	10187-103D7	71.94	13.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	91.69	23.67
adrenal gland, adult, pool1	10081-102A9	58.20	10.91
adult T-cell leukemia cell line:ATN-1	10421-106C7	93.92	23.35
alveolar cell carcinoma cell line:SW 1573	10708-109H6	93.26	18.22
amniotic membrane cells, donor1	12235-129G3	47.07	6.72
amniotic membrane cells, donor2	12236-129G4	58.15	9.47
amniotic membrane cells, donor3	12237-129G5	35.06	5.89
amygdala - adult, donor10196	10167-103B5	23.72	7.11
amygdala, adult, donor10252	10151-102I7	44.81	5.07
amygdala, newborn, donor10223	10360-105E9	43.57	5.49
anaplastic carcinoma cell line:8305C	10428-106D5	55.77	11.33
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	59.57	13.46
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	45.43	9.69
aorta, adult, pool1	10052-101G7	32.36	6.08
appendix, adult	10189-103D9	30.27	11.26
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	52.28	7.91
artery, adult	10190-103E1	52.99	4.08
astrocytoma cell line:TM-31	10425-106D2	124.30	8.84
b cell line:RPMI1788	10427-106D4	73.61	14.28
basal cell carcinoma cell line:TE 354.T	10702-109G9	101.27	18.87
bile duct carcinoma cell line:HuCCT1	10432-106D9	51.80	8.83
bile duct carcinoma cell line:TFK-1	10496-107C1	62.26	7.36
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	72.14	10.63
bladder, adult, pool1	10011-101C2	50.84	6.63
blood, adult, pool1	10053-101G8	46.51	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	100.19	11.99
bone marrow, adult	10192-103E3	59.38	8.77
brain, adult, donor1	10084-102B3	48.18	6.15
brain, adult, pool1	10012-101C3	49.33	8.13
brain, fetal, pool1	10085-102B4	58.77	8.01
breast carcinoma cell line:MCF7	10482-107A5	80.28	21.14
breast carcinoma cell line:MDA-MB-453	10419-106C5	109.59	13.36
breast, adult, donor1	10080-102A8	29.67	5.05
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	28.33	12.70
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	79.78	16.08
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	140.66	44.43
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	54.95	11.62
carcinoid cell line:NCI-H1770	10703-109H1	78.99	11.75
carcinoid cell line:NCI-H727	10735-110B6	95.49	17.17
carcinoid cell line:SK-PN-DW	10719-109I8	49.44	9.19
carcinosarcoma cell line:JHUCS-1	10642-109A3	52.97	10.65
caudate nucleus - adult, donor10196	10177-103C6	12.66	3.45
caudate nucleus, adult, donor10252	10164-103B2	48.19	7.86
caudate nucleus, adult, donor10258	10379-105H1	42.03	10.70
caudate nucleus, newborn, donor10223	10354-105E3	28.57	9.89
cerebellum - adult, donor10196	10173-103C2	46.61	5.83
cerebellum, adult, donor10252	10166-103B4	39.29	7.47
cerebellum, adult, pool1	10083-102B2	32.08	4.14
cerebellum, newborn, donor10223	10357-105E6	53.97	14.95
cerebral meninges, adult	10188-103D8	47.40	7.82
cerebrospinal fluid, donor2	10294-104G6	16.81	3.65
cervical cancer cell line:D98-AH2	10552-107I3	67.29	5.46
cervical cancer cell line:ME-180	10553-107I4	84.35	11.43
cervix, adult, pool1	10013-101C4	49.87	7.87
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	88.34	8.36
chondrosarcoma cell line:SW 1353	10700-109G7	43.11	11.76
choriocarcinoma cell line:BeWo	10423-106C9	93.21	19.01
choriocarcinoma cell line:SCH	10785-110H2	71.71	9.49
choriocarcinoma cell line:T3M-3	10618-108G6	77.79	23.72
chorionic membrane cells, donor1	12238-129G6	50.72	10.83
chorionic membrane cells, donor2	12239-129G7	69.10	10.14
chorionic membrane cells, donor3	12240-129G8	49.45	10.99
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	35.34	20.20
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	51.87	10.57
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	55.33	7.39
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	60.86	13.61
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.84	15.72
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	61.69	12.83
chronic myelogenous leukemia cell line:K562	10454-106G4	84.51	21.20
chronic myelogenous leukemia cell line:KU812	10409-106B4	44.57	5.21
clear cell carcinoma cell line:JHOC-5	10638-108I8	89.60	25.37
clear cell carcinoma cell line:TEN	10636-108I6	76.69	18.04
colon carcinoma cell line:CACO-2	10513-107D9	64.80	8.24
colon carcinoma cell line:COLO-320	10420-106C6	49.79	7.60
colon, adult, donor1	10082-102B1	36.89	3.57
colon, adult, pool1	10014-101C5	56.40	8.46
colon, fetal, donor1	10070-101I7	35.84	1.85
common myeloid progenitor CMP, donor1	12130-128D6	50.42	0.00
common myeloid progenitor CMP, donor2	12134-128E1	175.26	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	79.46	22.95
cord blood derived cell line:COBL-a 24h infection	10453-106G3	63.09	16.00
cord blood derived cell line:COBL-a untreated	10449-106F8	68.11	15.79
corpus callosum, adult, pool1	10042-101F6	56.61	8.40
cruciate ligament, donor2	10295-104G7	27.56	4.86
diaphragm, fetal, donor1	10069-101I6	31.30	5.62
diencephalon, adult	10193-103E4	37.68	5.76
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	50.06	12.17
ductal cell carcinoma cell line:KLM-1	10438-106E6	115.91	24.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	56.57	10.83
ductus deferens, adult	10196-103E7	48.34	5.98
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	4.32
duodenum, fetal, donor1, tech_rep2	10071-101I8	40.46	11.77
dura mater, adult, donor1	10041-101F5	44.35	7.27
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	90.16	22.65
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	84.83	14.90
embryonic pancreas cell line:1B2C6	10604-108F1	98.66	20.35
embryonic pancreas cell line:1C3D3	10605-108F2	93.23	25.43
embryonic pancreas cell line:1C3IKEI	10606-108F3	92.01	21.61
embryonic pancreas cell line:2C6	10603-108E9	118.21	26.27
endometrial carcinoma cell line:OMC-2	10497-107C2	197.43	29.50
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	112.00	22.65
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	57.73	14.31
epidermoid carcinoma cell line:A431	10426-106D3	52.02	6.45
epidermoid carcinoma cell line:Ca Ski	10431-106D8	58.95	10.34
epididymis, adult	10197-103E8	46.05	7.95
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	65.82	8.69
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.11	3.93
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	59.50	6.55
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	39.07	5.91
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	54.56	8.51
esophagus, adult, pool1	10015-101C6	45.87	5.84
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	64.75	9.14
eye - muscle inferior rectus, donor1	10272-104E2	16.90	2.41
eye - muscle lateral, donor2	10298-104H1	29.46	4.21
eye - muscle medial, donor2	10299-104H2	17.86	4.46
eye - muscle superior, donor2	10297-104G9	22.93	3.44
eye - vitreous humor, donor1	10268-104D7	10.20	2.91
eye, fetal, donor1	10054-101G9	34.83	7.37
fibrosarcoma cell line:HT-1080	10758-110E2	40.26	5.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	79.77	22.08
frontal lobe, adult, pool1	10040-101F4	40.53	6.19
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	125.80	14.71
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	116.58	29.35
gall bladder, adult	10198-103E9	42.73	6.28
gamma delta positive T cells, donor1	11937-126A2	60.13	12.35
gamma delta positive T cells, donor2	11938-126A3	59.76	11.58
gastric adenocarcinoma cell line:MKN1	10614-108G2	80.26	10.14
gastric adenocarcinoma cell line:MKN45	10612-108F9	80.46	14.51
gastric cancer cell line:AZ521	10549-107H9	32.46	7.05
gastric cancer cell line:GSS	10560-108A2	43.93	13.73
gastrointestinal carcinoma cell line:ECC12	10615-108G3	54.14	11.88
giant cell carcinoma cell line:LU65	10487-107B1	47.73	10.21
giant cell carcinoma cell line:Lu99B	10433-106E1	92.37	21.41
glassy cell carcinoma cell line:HOKUG	10688-109F4	30.93	6.73
glioblastoma cell line:A172, tech_rep1	10444-106F3	86.03	16.36
glioblastoma cell line:A172, tech_rep2	10444-106F3	101.68	18.12
glioblastoma cell line:T98G	10485-107A8	62.25	9.82
glioma cell line:GI-1	10413-106B8	44.52	3.81
globus pallidus - adult, donor10196	10175-103C4	40.09	8.02
globus pallidus, adult, donor10252	10161-103A8	55.17	10.01
globus pallidus, adult, donor10258	10367-105F7	80.78	8.22
globus pallidus, newborn, donor10223	10364-105F4	38.37	8.53
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	142.07	21.86
granulocyte macrophage progenitor, donor3	12139-128E6	135.89	31.36
granulosa cell tumor cell line:KGN	10624-108H3	56.64	7.04
hIPS +CCl2, biol_rep1	14383-156B9	40.40	10.10
hIPS +CCl2, biol_rep2	14384-156C1	28.35	7.77
hIPS +CCl2, biol_rep3	14385-156C2	38.65	11.59
hIPS, biol_rep1	14380-156B6	14.37	10.06
hIPS, biol_rep2	14381-156B7	26.75	7.54
hIPS, biol_rep3	14382-156B8	16.55	11.03
hairy cell leukemia cell line:Mo	10712-109I1	54.60	11.21
heart - mitral valve, adult	10205-103F7	38.57	3.89
heart - pulmonic valve, adult	10206-103F8	41.05	7.58
heart - tricuspid valve, adult	10207-103F9	43.30	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	42.85	7.75
heart, adult, diseased, donor1	10051-101G6	44.71	8.09
heart, adult, pool1	10016-101C7	64.16	7.59
heart, fetal, pool1	10046-101G1	42.51	5.65
hepatic mesenchymal tumor cell line:LI90	10778-110G4	68.49	12.65
hepatoblastoma cell line:HuH-6	10633-108I3	36.86	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	98.23	13.59
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	89.57	13.72
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	93.27	14.15
hepatoma cell line:Li-7	10484-107A7	99.65	9.12
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.38	9.85
hippocampus - adult, donor10196	10169-103B7	37.85	5.68
hippocampus, adult, donor10252	10153-102I9	43.27	10.00
hippocampus, adult, donor10258	10374-105G5	8.96	2.49
hippocampus, newborn, donor10223	10363-105F3	25.73	5.99
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	175.78	21.36
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	93.07	11.58
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	93.18	14.47
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	61.46	16.92
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	72.56	12.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.93	11.01
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	67.73	18.69
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	61.40	12.49
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.05	14.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	77.43	15.39
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	77.79	14.14
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	72.04	12.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	83.41	10.80
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	70.75	11.30
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	139.64	18.33
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	69.30	12.03
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	56.69	11.77
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	81.46	16.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	62.73	15.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	79.58	17.28
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	66.72	17.23
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	72.51	13.55
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	64.45	10.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	66.06	14.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	106.97	12.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	92.72	7.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	136.38	20.01
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	78.87	11.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	67.78	9.19
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	83.22	16.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	67.23	16.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	71.07	12.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	66.70	13.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	78.23	14.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	77.99	22.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	78.30	16.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	86.70	10.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	141.27	14.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	109.76	10.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	61.12	11.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	143.14	48.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	95.97	20.85
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	65.13	13.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.86	15.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	58.01	21.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	34.61	14.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	55.52	11.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	68.16	14.55
immature langerhans cells, donor1	11904-125F5	19.61	4.12
immature langerhans cells, donor2	11905-125F6	32.48	4.75
insula, adult, pool1	10039-101F3	48.55	7.76
keratoacanthoma cell line:HKA-1	10791-110H8	62.75	6.50
kidney, adult, pool1	10017-101C8	73.69	10.01
kidney, fetal, pool1	10045-101F9	55.95	6.30
large cell lung carcinoma cell line:IA-LM	10509-107D5	70.16	15.20
large cell lung carcinoma cell line:NCI-H460	10839-111E2	49.21	10.37
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	104.23	30.09
left atrium, adult, donor1	10079-102A7	34.33	3.27
left ventricle, adult, donor1	10078-102A6	45.51	5.56
leiomyoblastoma cell line:G-402	10721-110A1	46.79	9.85
leiomyoma cell line:10964C	10569-108B2	59.28	16.53
leiomyoma cell line:15242A	10570-108B3	61.41	20.65
leiomyoma cell line:15425	10571-108B4	68.47	18.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	40.78	7.32
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	80.99	10.27
liposarcoma cell line:KMLS-1	10782-110G8	45.46	8.12
liposarcoma cell line:SW 872	10726-110A6	53.73	11.33
liver, adult, pool1	10018-101C9	84.27	9.56
liver, fetal, pool1	10086-102B5	59.26	8.47
locus coeruleus - adult, donor10196	10182-103D2	43.31	6.42
locus coeruleus, adult, donor10252	10165-103B3	56.84	8.67
locus coeruleus, adult, donor10258	10375-105G6	67.71	7.90
locus coeruleus, newborn, donor10223	10362-105F2	50.47	9.67
lung adenocarcinoma cell line:A549	10499-107C4	89.96	14.67
lung adenocarcinoma cell line:PC-14	10408-106B3	66.18	13.79
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	73.42	20.43
lung, adult, pool1	10019-101D1	54.34	6.97
lung, fetal, donor1	10068-101I5	19.98	5.71
lung, right lower lobe, adult, donor1	10075-102A3	36.66	7.79
lymph node, adult, donor1	10077-102A5	31.24	5.21
lymphangiectasia cell line:DS-1	10727-110A7	79.34	7.23
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	41.96	13.43
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	67.96	9.34
mature adipocyte, donor1	12231-129F8	47.06	12.88
mature adipocyte, donor2	12232-129F9	51.05	12.04
mature adipocyte, donor3	12233-129G1	53.10	11.14
mature adipocyte, donor4	12234-129G2	58.96	15.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	50.27	14.53
medial frontal gyrus - adult, donor10196	10170-103B8	33.84	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	41.75	5.33
medial frontal gyrus, adult, donor10258	10368-105F8	34.63	8.90
medial frontal gyrus, newborn, donor10223	10352-105E1	57.15	14.07
medial temporal gyrus - adult, donor10196	10183-103D3	48.60	8.44
medial temporal gyrus, adult, donor10252	10156-103A3	48.39	7.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	36.61	9.69
medulla oblongata - adult, donor10196	10174-103C3	51.92	6.49
medulla oblongata, adult, donor10252	10155-103A2	41.95	8.36
medulla oblongata, adult, pool1	10038-101F2	37.96	6.45
medulla oblongata, newborn, donor10223	10361-105F1	36.80	8.33
medulloblastoma cell line:D283 Med	10838-111E1	28.12	5.98
medulloblastoma cell line:ONS-76	10759-110E3	56.73	11.74
melanoma cell line:COLO 679	10514-107E1	37.09	8.19
melanoma cell line:G-361	10465-106H6	57.82	12.49
meningioma cell line:HKBMM	10691-109F7	76.88	14.65
merkel cell carcinoma cell line:MKL-1	10843-111E6	51.11	10.57
merkel cell carcinoma cell line:MS-1	10844-111E7	46.66	10.11
mesenchymal precursor cell - adipose, donor1	11747-123G1	69.35	13.96
mesenchymal precursor cell - adipose, donor2	11748-123G2	54.35	8.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	45.14	10.35
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	38.63	6.74
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.22	6.74
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	63.16	8.33
mesenchymal precursor cell - cardiac, donor1	11752-123G6	78.78	7.90
mesenchymal precursor cell - cardiac, donor2	11753-123G7	42.21	6.21
mesenchymal precursor cell - cardiac, donor3	11754-123G8	51.07	9.68
mesenchymal precursor cell - cardiac, donor4	11755-123G9	60.90	13.77
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	45.38	13.37
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	68.84	12.19
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	69.60	14.81
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	88.67	15.71
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	62.07	15.52
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	57.51	15.82
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	50.17	7.86
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	55.63	12.54
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.45	19.30
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	46.18	10.01
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	61.97	11.29
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	42.71	9.94
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	58.95	12.59
mesenchymal stem cell line:Hu5/E18	10568-108B1	103.99	24.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	58.00	6.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	52.18	10.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	60.20	9.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	56.07	5.55
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	44.25	8.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	54.49	12.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	49.12	8.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	46.80	10.66
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	61.72	8.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	47.97	11.38
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	59.61	8.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	60.13	5.87
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	46.66	9.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	47.49	10.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	33.51	11.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	54.69	13.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	61.98	20.66
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	73.08	11.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	75.66	8.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	86.36	13.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	70.33	8.18
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	64.92	12.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	92.34	10.49
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	77.49	8.94
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	76.49	16.01
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	68.23	13.40
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	76.64	7.60
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	60.70	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	64.48	12.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	48.21	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	45.64	6.52
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	34.16	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.78	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	26.81	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	36.09	4.01
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	46.12	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	43.37	6.20
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	71.75	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	56.08	7.85
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	68.06	8.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	76.16	9.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	89.40	10.90
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	51.95	15.20
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	70.40	7.28
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	94.90	18.08
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	70.84	9.88
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	62.50	5.75
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	54.19	8.11
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	65.19	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	46.42	6.96
mesothelioma cell line:ACC-MESO-1	10493-107B7	106.78	30.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	104.25	16.45
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	76.92	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	165.94	30.31
mesothelioma cell line:Mero-25	10850-111F4	33.14	7.49
mesothelioma cell line:Mero-41	10851-111F5	42.29	9.53
mesothelioma cell line:Mero-48a	10852-111F6	48.94	15.94
mesothelioma cell line:Mero-82	10853-111F7	59.13	11.30
mesothelioma cell line:Mero-83	10854-111F8	25.87	5.62
mesothelioma cell line:Mero-84	10855-111F9	61.42	8.59
mesothelioma cell line:Mero-95	10856-111G1	36.85	6.42
mesothelioma cell line:NCI-H2052	10847-111F1	79.18	20.21
mesothelioma cell line:NCI-H226	10846-111E9	46.88	9.95
mesothelioma cell line:NCI-H2452	10848-111F2	63.55	14.52
mesothelioma cell line:NCI-H28	10845-111E8	39.70	9.42
mesothelioma cell line:No36	10857-111G2	48.93	7.50
mesothelioma cell line:ONE58	10858-111G3	58.25	11.11
migratory langerhans cells, donor1	11901-125F2	66.60	22.07
migratory langerhans cells, donor2	11902-125F3	43.35	14.29
migratory langerhans cells, donor3	11903-125F4	54.92	14.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	80.31	13.06
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	108.51	21.19
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	64.04	5.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	44.15	11.04
myelodysplastic syndrome cell line:SKM-1	10772-110F7	110.69	18.11
myeloma cell line:PCM6	10474-106I6	155.17	13.24
myxofibrosarcoma cell line:MFH-ino	10600-108E6	57.32	9.13
myxofibrosarcoma cell line:NMFH-1	10684-109E9	83.56	20.79
nasal epithelial cells, donor1, tech_rep1	12226-129F3	93.93	22.73
nasal epithelial cells, donor1, tech_rep2	12226-129F3	97.07	23.75
nasal epithelial cells, donor2	12227-129F4	45.82	6.07
neuroblastoma cell line:CHP-134	10508-107D4	53.60	10.81
neuroblastoma cell line:NB-1	10539-107G8	58.37	7.48
neuroblastoma cell line:NBsusSR	10607-108F4	64.95	12.23
neuroblastoma cell line:NH-12	10555-107I6	30.93	5.59
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	27.76	6.17
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	35.32	8.39
neuroectodermal tumor cell line:TASK1	10774-110F9	68.03	4.43
neuroepithelioma cell line:SK-N-MC	10728-110A8	45.14	19.07
neurofibroma cell line:Hs 53.T	10729-110A9	72.66	11.71
neutrophil PMN, donor1	12133-128D9	44.62	0.00
neutrophil PMN, donor2	12137-128E4	66.40	13.28
neutrophil PMN, donor3	12141-128E8	132.59	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	95.89	13.19
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	96.86	16.81
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	64.12	10.90
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	89.87	10.25
nucleus accumbens, adult, pool1	10037-101F1	37.96	6.19
occipital cortex - adult, donor10196	10172-103C1	41.21	12.36
occipital cortex, adult, donor10252	10163-103B1	46.43	8.05
occipital cortex, newborn, donor10223	10355-105E4	35.67	3.28
occipital lobe, adult, donor1	10076-102A4	40.67	4.72
occipital lobe, fetal, donor1	10073-102A1	41.19	12.01
occipital pole, adult, pool1	10036-101E9	34.61	4.97
olfactory region, adult	10195-103E6	36.30	6.11
optic nerve, donor1	10277-104E7	46.02	8.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	36.79	5.58
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	78.04	10.85
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	56.55	7.79
oral squamous cell carcinoma cell line:SAS	10544-107H4	57.64	11.78
osteoclastoma cell line:Hs 706.T	10704-109H2	74.37	13.52
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	159.77	18.69
osteosarcoma cell line:HS-Os-1	10558-107I9	28.20	2.54
ovary, adult, pool1	10020-101D2	32.84	4.45
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	103.39	19.25
pancreas, adult, donor1	10049-101G4	98.77	11.29
pancreatic carcinoma cell line:NOR-P1	10698-109G5	52.55	8.11
papillary adenocarcinoma cell line:8505C	10437-106E5	51.62	10.22
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	49.18	5.46
paracentral gyrus, adult, pool1	10035-101E8	42.01	6.22
parietal cortex, adult, donor10258	10373-105G4	24.22	6.61
parietal lobe - adult, donor10196	10171-103B9	26.33	3.76
parietal lobe, adult, donor10252	10157-103A4	41.05	5.13
parietal lobe, adult, pool1	10034-101E7	41.94	5.82
parietal lobe, fetal, donor1	10072-101I9	42.67	8.73
parietal lobe, newborn, donor10223	10356-105E5	44.49	6.36
parotid gland, adult	10199-103F1	51.80	23.43
penis, adult	10200-103F2	35.99	8.06
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	55.97	15.80
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	99.95	15.44
pineal gland - adult, donor10196	10179-103C8	27.09	12.26
pineal gland, adult, donor10252	10160-103A7	42.64	10.07
pineal gland, adult, donor10258	10377-105G8	41.39	4.39
pituitary gland - adult, donor10196	10180-103C9	31.37	10.12
pituitary gland, adult, donor10252	10162-103A9	39.09	5.73
pituitary gland, adult, donor10258	10378-105G9	35.75	3.40
placenta, adult, pool1	10021-101D3	58.05	8.39
plasma cell leukemia cell line:ARH-77	10840-111E3	58.67	15.63
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	58.05	9.49
pons, adult, pool1	10033-101E6	36.23	6.63
postcentral gyrus, adult, pool1	10032-101E5	40.36	5.40
promyelocytes/myelocytes PMC, donor1	12132-128D8	39.74	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	137.70	27.54
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	11.74
prostate cancer cell line:DU145	10490-107B4	61.47	8.01
prostate cancer cell line:PC-3	10439-106E7	132.86	19.24
prostate, adult, pool1	10022-101D4	38.00	7.26
putamen, adult, donor10196	10176-103C5	48.39	12.98
putamen, adult, donor10252	10152-102I8	49.02	15.69
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	31.89	5.07
putamen, newborn, donor10223	10365-105F5	82.46	22.49
rectal cancer cell line:TT1TKB	10469-106I1	76.22	10.47
rectum, fetal, donor1	10067-101I4	34.77	13.91
renal cell carcinoma cell line:OS-RC-2	10411-106B6	62.54	13.99
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	78.29	26.10
retina, adult, pool1	10030-101E3	48.61	8.95
retinoblastoma cell line:Y79	10475-106I7	80.54	15.85
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.68	4.06
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	85.20	15.75
sacrococcigeal teratoma cell line:HTST	10695-109G2	86.40	8.34
salivary acinar cells, donor1	11771-123I7	27.84	4.69
salivary acinar cells, donor2	11772-123I8	29.47	5.09
salivary acinar cells, donor3	11773-123I9	30.45	7.94
salivary gland, adult, pool1	10093-102C3	67.49	7.44
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	67.03	13.32
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	89.81	16.93
seminal vesicle, adult	10201-103F3	59.26	9.52
serous adenocarcinoma cell line:JHOS-2	10639-108I9	53.20	11.42
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	42.27	10.32
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	64.23	14.05
serous cystadenocarcinoma cell line:HTOA	10693-109F9	55.21	9.40
signet ring carcinoma cell line:Kato III	10436-106E4	56.92	7.52
signet ring carcinoma cell line:NUGC-4	10483-107A6	64.51	10.45
skeletal muscle - soleus muscle, donor1	10282-104F3	45.40	7.80
skeletal muscle, adult, pool1	10023-101D5	52.17	12.23
skeletal muscle, fetal, donor1	10066-101I3	27.14	2.01
skin, adult, donor1	10074-102A2	40.71	13.57
skin, fetal, donor1	10065-101I2	35.35	4.42
small cell cervical cancer cell line:HCSC-1	10800-110I8	44.03	21.01
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	42.55	3.78
small cell lung carcinoma cell line:DMS 144	10841-111E4	98.30	37.78
small cell lung carcinoma cell line:LK-2	10541-107H1	88.02	14.18
small cell lung carcinoma cell line:NCI-H82	10842-111E5	53.88	25.25
small cell lung carcinoma cell line:WA-hT	10562-108A4	52.08	7.63
small intestine, adult, pool1	10024-101D6	74.17	8.12
small intestine, fetal, donor1	10064-101I1	38.82	4.91
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	60.52	11.28
smooth muscle, adult, pool1	10048-101G3	26.10	2.58
somatostatinoma cell line:QGP-1	10781-110G7	138.83	19.30
spinal cord - adult, donor10196	10181-103D1	49.55	8.26
spinal cord, adult, donor10252	10159-103A6	46.13	7.10
spinal cord, adult, donor10258	10369-105F9	33.21	9.69
spinal cord, fetal, donor1	10056-101H2	40.25	4.27
spinal cord, newborn, donor10223	10359-105E8	57.40	11.48
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	67.81	14.94
spleen, adult, pool1	10025-101D7	44.38	5.95
spleen, fetal, pool1	10044-101F8	40.05	6.20
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	65.32	9.94
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	99.49	12.15
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	48.92	9.44
squamous cell carcinoma cell line:T3M-5	10616-108G4	78.97	19.94
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	56.84	6.98
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	54.64	12.71
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	36.81	6.77
stomach, fetal, donor1	10062-101H8	55.53	10.68
submaxillary gland, adult	10202-103F4	57.54	11.39
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27
substantia nigra, adult, donor10252	10158-103A5	60.23	8.72
substantia nigra, adult, donor10258	10371-105G2	17.07	7.76
substantia nigra, newborn, donor10223	10358-105E7	38.16	9.19
synovial sarcoma cell line:HS-SY-II	10441-106E9	58.92	16.28
temporal lobe, adult, pool1	10031-101E4	48.23	7.04
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	29.20	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	27.25	7.47
tenocyte, donor1	11763-123H8	49.57	5.59
tenocyte, donor2	11765-123I1	47.31	5.72
tenocyte, donor3	11768-123I4	49.30	9.27
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	84.13	17.68
teratocarcinoma cell line:NCR-G1	10798-110I6	57.96	9.56
teratocarcinoma cell line:PA-1	10807-111A6	48.35	5.42
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	62.46	12.19
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	97.57	17.77
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	49.84	5.45
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	102.60	57.98
testis, adult, pool1	10026-101D8	48.32	27.38
testis, adult, pool2	10096-102C6	45.56	38.34
thalamus - adult, donor10196	10168-103B6	49.68	11.04
thalamus, adult, donor10252	10154-103A1	50.95	7.50
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	42.49	5.27
thalamus, newborn, donor10223	10366-105F6	36.25	8.63
throat, adult	10209-103G2	38.70	7.24
throat, fetal, donor1	10061-101H7	29.86	5.79
thymic carcinoma cell line:Ty-82	10803-111A2	56.24	8.94
thymus, adult, pool1	10027-101D9	33.60	13.12
thymus, fetal, pool1	10043-101F7	48.63	10.91
thyroid carcinoma cell line:KHM-5M	10776-110G2	85.23	15.69
thyroid carcinoma cell line:TCO-1	10783-110G9	63.98	14.25
thyroid, adult, pool1	10028-101E1	59.25	10.73
thyroid, fetal, donor1	10060-101H6	30.85	5.27
tongue epidermis (fungiform papillae), donor1	10288-104F9	33.88	0.00
tongue, adult	10203-103F5	43.26	5.35
tongue, fetal, donor1	10059-101H5	36.65	6.70
tonsil, adult, pool1	10047-101G2	51.89	8.62
trachea, adult, pool1	10029-101E2	42.94	6.22
trachea, fetal, donor1	10058-101H4	27.70	5.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	60.23	12.75
transitional-cell carcinoma cell line:5637	10418-106C4	75.18	13.78
transitional-cell carcinoma cell line:JMSU1	10492-107B6	81.01	11.28
tridermal teratoma cell line:HGRT	10694-109G1	72.30	11.42
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	48.42	7.03
umbilical cord, fetal, donor1	10057-101H3	29.21	8.35
uterus, adult, pool1	10100-102D1	32.42	6.65
uterus, fetal, donor1	10055-101H1	43.00	6.14
vagina, adult	10204-103F6	21.97	3.88
vein, adult	10191-103E2	37.48	11.40
xeroderma pigentosum b cell line:XPL 17	10563-108A5	48.87	11.48